KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to -$201.3 million.

  • Encompass Health's Cash from Investing Activities fell 2464.4% to -$201.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$728.9 million, marking a year-over-year decrease of 1082.56%. This contributed to the annual value of -$653.3 million for FY2024, which is 837.76% down from last year.
  • Per Encompass Health's latest filing, its Cash from Investing Activities stood at -$201.3 million for Q3 2025, which was down 2464.4% from -$165.4 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Cash from Investing Activities ranged from a high of -$95.6 million in Q1 2021 and a low of -$226.0 million during Q2 2021
  • Over the past 5 years, Encompass Health's median Cash from Investing Activities value was -$161.5 million (recorded in 2024), while the average stood at -$161.8 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 14538.55% in 2021, then soared by 4548.67% in 2022.
  • Encompass Health's Cash from Investing Activities (Quarter) stood at -$220.7 million in 2021, then increased by 6.48% to -$206.4 million in 2022, then decreased by 0.82% to -$208.1 million in 2023, then rose by 2.11% to -$203.7 million in 2024, then increased by 1.18% to -$201.3 million in 2025.
  • Its last three reported values are -$201.3 million in Q3 2025, -$165.4 million for Q2 2025, and -$158.5 million during Q1 2025.